Clinical Cell Culture renames
Tuesday, 10 June, 2008
Clinical Cell Culture (ASX: CCE) is to be re-named Avita Medical following a shareholder meeting.
The resolution to change the company's name was passed by the vast majority of shareholders.
Shareholders have also resolved to consolidate the company's shares on a 10:1 basis.
The company believes that a name change and the recent shake-up of the boardroom will help drive sales of the company's products, such as the ReCell autologous skin cell kit, further.
Sunscreen and supplements can lower your vitamin D levels
People who use SPF50+ sunscreen daily are more likely to be vitamin D deficient, while taking...
Low-dose drug prevents diabetes progression in young people
A low dose of the immunomodulatory drug anti-thymocyte globulin (ATG) appears safe and effective...
Mediterranean-style diet benefits maternal and infant health
Two studies have found that a Mediterranean-style diet benefits maternal health during pregnancy...
